MedPath

Nasatapp

Brand Name: Nasatapp

Generic Name: Phenylpropanolamine Hydrochloride + Brompheniramine Maleate

Active
Registration Number

DR-XY24538

Dosage Form

Syrup (Oral Drops)

Issuance Date

August 1, 2023

Expiry Date

December 4, 2028

Product Information

Philippine FDA product specifications and classification details

Product Specifications

Dosage Strength6.25 mg/2 mg per mL
PackagingAmber Glass Bottle x 15 mL with Dropper (Box of l's)

Classification

C
Classification
Prescription Drug (RX)
P
Pharmacologic
Nasal Decongestant/Antihistamine
A
Application
Renewal
Philippine FDA Classification

Active Ingredients (2)

Complete list of active ingredients in this pharmaceutical product.

Phenylpropanolamine HydrochlorideActive
Brompheniramine MaleateActive
Monograph: Brompheniramine

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

MedPath - Medical Intelligence Platform